JPMorgan has downgraded India's stock market rating to Neutral from Overweight, delivering a significant blow to investor sentiment. The investment bank has warned that the Nifty could plunge to 20,500 in a bear-case scenario, implying a sharp 15% drop from current levels. According to The Economic Times, while India's long-term structural story remains intact, near-term tactical headwinds call for patience. The brokerage cited elevated valuations, Iran war uncertainty, and energy disruptions as key factors justifying the more cautious stance, noting that although the valuation gap has started to narrow, it continues to remain elevated.
JPMorgan has cut FY27 earnings estimates by 2% to 10% across key segments and lowered its CY26E and CY27E MSCI India EPS growth forecasts by 2% and 1% to 11% and 13%, respectively. The brokerage highlighted that India's largecap universe lacks meaningful exposure to high-growth themes such as AI, data centres and semiconductors compared to markets like the US, Korea, China, and Taiwan. Within sectors, JPMorgan remains overweight on Financials, Materials, Consumer Discretionary, Hospitals, Defence and Power, while staying underweight on IT and Pharma. The revised Nifty 50 targets now stand at 30,000 (bull case), 27,000 (base case), and 20,500 (bear case), compared to earlier estimates of 33,000, 30,000, and 24,000 respectively.
IDFC First Bank is expected to report a muted Q4FY26 performance with profitability likely to remain under pressure due to the impact of a recent deposit fraud, even as core operating metrics stay resilient on the back of healthy loan growth and stable margins. According to The Economic Times, Nomura estimates PAT at ₹50 crore, down 84% YoY and 90% QoQ, while Nuvama expects PAT at ₹200 crore, down 36% YoY and 61% QoQ. ICICI Securities pegs PAT at ₹407 crore, up 34% YoY but down 19.1% QoQ, and Motilal Oswal estimates PAT at ₹160 crore, down 47% YoY and 68% QoQ. Net Interest Income (NII) is expected to grow steadily in the range of 14%-19%, with Nomura estimating NII at ₹5,610 crore, up 14% YoY and 2% QoQ, and Nuvama seeing NII at ₹5,830 crore, up 19% YoY and 6% QoQ. The private lender will announce its January-March quarter earnings on Saturday, April 25.
Brokerages remain selective but constructive on the asset management space, with Motilal Oswal maintaining a bullish stance on UTI AMC and Aditya Birla Sun Life AMC. According to reports from The Economic Times, the brokerage cites steady AUM trends, strong SIP inflows, and improving long-term growth visibility despite near-term margin pressures. The positive outlook reflects confidence in the steady growth trajectory of these asset management companies amid evolving market dynamics.
In contrast to the positive AMC sentiment, Goldman Sachs has adopted a more cautious view on Dr. Reddy's, as reported by The Economic Times. The investment bank has downgraded the stock on weak pipeline visibility, pricing pressure and limited near-term growth opportunities. This downgrade reflects concerns about the pharmaceutical company's ability to navigate current market challenges and capitalize on growth opportunities in the near term.
